| Tissue Specificity | Expressed in pancreas, heart, leukocyte and spleen. Expressed in both resting and activated peripheral blood T-cells. Expressed in breast cancer. |
| Post Translational Modifications | Constitutively tyrosine-phosphorylated. Phosphorylated by TEC. Phosphorylated by LYN. Phosphorylated on tyrosine residues by the insulin receptor kinase. Results in the negative regulation of the insulin signaling pathway. Phosphorylated on tyrosine residues by SRMS. |
| Function | DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK1 appears to be a negative regulator of the insulin signaling pathway. Modulates integrin activation by competing with talin for the same binding site on ITGB3. |
| Protein Name | Docking Protein 1Downstream Of Tyrosine Kinase 1P62(DokPp62 |
| Database Links | Reactome: R-HSA-8849469Reactome: R-HSA-8853659 |
| Cellular Localisation | Isoform 1: CytoplasmNucleusIsoform 3: CytoplasmPerinuclear Region |
| Alternative Antibody Names | Anti-Docking Protein 1 antibodyAnti-Downstream Of Tyrosine Kinase 1 antibodyAnti-P62(Dok antibodyAnti-Pp62 antibodyAnti-DOK1 antibody |
Information sourced from Uniprot.org
